The NMC guidelines 2026 have raised important questions about how doctors and hospitals in India can promote their services online. From influencer marketing and social media posts to patient testimonials and AI-generated content, healthcare professionals need to understand the rules before publishing promotional material. This guide explains the key restrictions and practical steps doctors, hospitals, brands, and creators should consider.

1. NMC Guidelines 2026 for Doctors and Hospitals: What Has Changed?

Imagine a hospital planning an Instagram campaign with a popular creator. The video features a specialist, explains a treatment, and encourages viewers to book an appointment. The marketing team sees a straightforward campaign. However, under India’s medical ethics framework, the same video can raise serious questions about patient solicitation, professional endorsements, and commercial promotion.

This is why the NMC guidelines 2026 for doctors and hospitals matter to healthcare marketers. On 6 October 2026, the National Medical Commission issued its Guidelines on Ethical Advertising and Public Communication by Hospitals/Medical Institutions and Registered Medical Practitioners. The notice directed relevant stakeholders to comply immediately. The guidelines address digital promotion, misleading claims, patient privacy, and the responsibilities of third parties. Read the official NMC notice and guidelines.

For doctors and hospitals, the practical question is no longer simply whether social media can support public awareness. It is whether each post, video, creator collaboration, or paid campaign stays within the applicable rules. A creator’s popularity does not make a prohibited promotion acceptable. Likewise, calling an advertisement “educational” does not automatically make it compliant.

1.1 What do the new guidelines mean for influencer marketing?

The short answer is that healthcare influencer marketing needs much stricter review. Doctors cannot assume they can hire influencers to promote their professional services. The guidelines restrict registered medical practitioners from engaging third parties to market medical services and from allowing their name, image, voice, testimonial, or endorsement to promote services or products. Hospitals and medical institutions must also assess their advertising against the guidelines and applicable state laws.

However, that does not mean every health-related video or public discussion is prohibited. The guidelines allow health-awareness programmes, public-health campaigns, academic discussions, and educational content under specified conditions. Such activity must not promote a doctor’s personal practice, solicit patients, or become promotional marketing. The purpose and execution matter.

This distinction affects every participant in a healthcare campaign: the doctor, hospital, creator, agency, platform, and brand partner. Each needs to understand what the content communicates and who benefits from it. A safer approach begins with the rules, not the campaign concept.

1.2 Why this is important for India’s healthcare marketing industry

Patients often turn to search engines, Instagram, YouTube, and online communities before choosing a healthcare provider. Consequently, digital communication can shape expectations before a patient ever visits a clinic. A polished video may look trustworthy even when its claims lack proper evidence.

That creates a responsibility for healthcare marketers. They must avoid content that pressures patients, exaggerates treatment results, or makes a doctor appear more qualified than the available evidence supports. They must also protect patient information and avoid presenting vulnerable people as promotional material.

For agencies, the change requires more than adding a disclaimer to the final video. Teams need a review process for scripts, claims, creator selection, patient material, paid distribution, and final publication. They should document approvals and seek qualified legal advice where interpretation remains uncertain. In healthcare, a campaign that attracts attention but undermines patient trust can cause lasting damage.

2. What the NMC Guidelines Allow and Prohibit in Digital Healthcare Marketing

The guidelines should not be reduced to a simple statement that “doctors cannot use social media.” They draw a distinction between responsible public communication and promotional activity. Therefore, hospitals and agencies need to examine the content’s purpose, claims, audience, and call to action.

The Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 remain an important part of the framework. The NMC’s new guidelines must be read alongside applicable laws and operative regulations. For hospitals, the relevant Clinical Establishments Act or state legislation may also apply. Where a conflict exists, the guidelines explain that the applicable statutory provisions prevail.

The table below offers a practical starting point. It is a marketing guide, not a substitute for reviewing the full official document.

The official document should always be checked before approving a campaign because a short summary cannot capture every condition or exception. The Indian Express explainer on the new rules also outlines the restrictions on advertising, offers, misleading claims, and AI content.

2.1 Can doctors post educational Reels and YouTube videos?

Yes, educational communication can remain possible when it meets the applicable requirements. A doctor explaining the general signs of dehydration, describing how vaccinations protect communities, or discussing preventive health may provide a public benefit. The content should remain factual, relevant to the doctor’s expertise, and focused on education rather than acquiring patients.

For example, a short video explaining when people should seek urgent medical help can offer useful information without promoting a particular clinic. By contrast, a video that turns the same explanation into a sales pitch for a doctor’s consultation may cross into prohibited promotional activity.

The distinction is not simply whether the doctor mentions a hospital. Marketers should examine the entire message, including the opening hook, visuals, spoken claims, captions, links, and final call to action. A disclaimer cannot repair content whose central purpose is prohibited solicitation.

Before publishing, the medical reviewer should verify clinical statements against reliable evidence. The communications team should also remove unsupported promises, unnecessary fear, and claims that encourage needless tests or treatment. Health education should help people make informed decisions, not frighten them into booking an appointment.

2.2 Can hospitals advertise their facilities and services?

Hospitals and medical institutions have specific responsibilities under the guidelines. Factual information about infrastructure and facilities may be communicated within the applicable rules. However, hospitals should not assume that every conventional advertising technique is acceptable in healthcare.

A facility description can explain available departments, accessibility, diagnostic equipment, or operating hours. Yet a campaign that promises a guaranteed cure or claims a hospital is the “best” without verifiable support creates a different problem. Promotional language can influence patients who may be worried, in pain, or under pressure to make a quick decision.

Hospitals must also consider applicable state legislation and Clinical Establishments Act requirements. The new NMC guidelines state that these rules should be read together, with relevant statutory provisions taking precedence where they conflict. This makes local legal review important, especially for multi-state hospital groups.

Marketing teams should create an approved information sheet containing verified facility details, service descriptions, qualifications, and the evidence behind any measurable claim. They should then use that source when preparing website pages, social posts, brochures, and creator briefs. This simple process reduces inconsistent claims across channels.

2.3 Why the 2023 professional conduct regulations need careful interpretation

Some online discussions refer to the NMC Registered Medical Practitioner (Professional Conduct) Regulations, 2023, as though every provision in that document remains operative. However, the NMC’s amendment notification dated 23 August 2023 placed those regulations in abeyance and restored the Indian Medical Council’s 2002 ethics regulations until further notification. The new October 2026 advertising guidelines add a current framework for digital and promotional communication.

That history matters because an outdated summary can mislead a hospital or agency about the rules currently applicable. Marketers should use the latest official notices rather than relying on old blog posts, screenshots, or social media summaries. They should also distinguish binding regulations from drafts, advisories, news reporting, and commentary.

For a compliance-sensitive campaign, record the title and date of the official document used during review. If the NMC later issues a clarification or amendment, the team can identify which content needs reassessment. This habit is particularly important for agencies managing many doctors and facilities across different locations.

3. Can Doctors, Hospitals, and Creators Work Together Under the New Rules?

Healthcare campaigns often involve several parties. A hospital may commission an agency, the agency may hire a creator, and the creator may publish a Reel or YouTube video. However, adding intermediaries does not automatically remove the medical advertising restrictions.

The new guidelines state that using a digital platform, advertising agency, influencer, or other intermediary does not, by itself, absolve a doctor or medical institution of responsibility for content they authorised, commissioned, sponsored, adopted, or knowingly permitted. Responsibility and consequences depend on the applicable law and the competent authority’s determination.

That principle should shape every campaign agreement. A hospital should not approve a concept simply because an external creator produced it. Likewise, an agency should not assume that the client carries every risk. All parties need a clear understanding of the content, claims, permissions, and publication plan.

3.1 What about a creator who reviews a hospital?

A creator might want to document a hospital visit, discuss a personal experience, or publish a sponsored review. These formats require careful examination because they can become testimonials or promotional endorsements. The rules governing medical professionals and institutions may restrict the underlying promotion even if a creator describes the video as an honest opinion.

A creator should not be asked to claim that a treatment cured a condition, that a doctor guarantees success, or that one hospital is superior without reliable and permissible substantiation. Nor should the creator use patient footage, clinical images, or private information without appropriate legal review and safeguards.

The first question should be whether the proposed collaboration is permissible at all. Only after that should the team discuss production, disclosures, platform formats, or fees. A clear contract cannot make a prohibited activity lawful, and a disclosure cannot turn a forbidden endorsement into an acceptable campaign.

Where a proposed activity falls into an uncertain area, the parties should obtain advice from a lawyer familiar with medical advertising and professional ethics. If approval cannot be established, the safer choice is to redesign the activity as genuine public-health education without promotional solicitation—or not publish it.

3.2 Can a health influencer discuss a medical condition?

A creator can share general health information, but creators should avoid acting as substitutes for qualified medical professionals. They should not diagnose viewers through comments, recommend individual treatment without appropriate clinical assessment, or present unsupported claims as medical fact.

For a compliant educational collaboration, a creator might host a general conversation about preventive health with an appropriately qualified expert. The discussion should focus on evidence, common questions, and when people should seek professional care. It should not be structured as a sales funnel for the expert’s private practice.

Even then, the campaign needs careful review. If a doctor participates, the content must comply with the professional rules applicable to that doctor. If a hospital sponsors the content, the institution must also assess its responsibilities. The creator’s own obligations, including applicable advertising-disclosure rules, may apply separately.

A sensible workflow uses a medically reviewed script, verified references, clear roles, and an agreed correction process. The creator should know which claims they can make, which claims need qualification, and which questions they should refer to a qualified clinician. That protects the audience and reduces the chance of misleading health information spreading widely.

3.3 Can a doctor promote medicines, supplements, or medical devices through a creator?

Doctors should not lend their name, photograph, voice, professional status, or endorsement to advertise a drug, medicine, remedy, therapeutic article, medical device, diagnostic product, health product, or other commercial product in the prohibited circumstances described by the guidelines. The restriction applies whether or not the doctor receives money or another benefit.

Therefore, a paid creator campaign should never assume that a doctor’s participation is acceptable merely because the product is legally sold. The medical endorsement itself can create a separate professional conduct issue. Agencies should review the product category, the proposed claims, the doctor’s role, and the campaign’s overall purpose before proceeding.

This also means a brand should not try to work around the restriction by asking a doctor to record a testimonial that an influencer later posts. Changing who uploads the content does not remove the substance of the endorsement.

Where a health product requires advertising review under other laws, those rules must also be checked. A campaign may need separate review for drug advertising, consumer protection, product claims, and platform requirements. Compliance is not a single checkbox; it involves the complete communication and the legal rules that apply to it.

4. Patient Testimonials, AI Content, and Other High-Risk Marketing Practices

The new framework makes patient protection central to healthcare communication. That matters because patient stories can be persuasive, but they can also expose private information or place pressure on people who are seeking treatment. A patient’s willingness to participate does not automatically make every proposed use appropriate.

The guidelines state that patient consent alone does not make permissible a testimonial, endorsement, promotional patient story, before-and-after depiction, success claim, or other advertising practice that is otherwise prohibited. Where consent is legally required, it must be specific, informed, voluntary, documented, and capable of verification. Applicable privacy and data-protection requirements also matter.

The same care applies to images, videos, medical records, treatment details, and other information that could identify a patient. Teams should minimise the information they collect and publish only what the applicable rules allow. Cropping a face may not be enough if other details identify the person.

4.1 Why before-and-after photos and success stories need special care

Before-and-after photos can create the impression that a particular doctor or hospital guarantees a specific outcome. Yet results can vary depending on the condition, medical history, treatment choice, and many other factors. A single example may not represent the likely experience of another patient.

The guidelines restrict the use of patient success stories, before-and-after photographs, and celebrity patients for promotional purposes. They also explain that consent does not override a prohibition. Therefore, a hospital should not assume that a signed release permits a promotional transformation video.

Educational or scientific uses may be treated differently where the applicable requirements are satisfied. However, a marketing team should not decide that an advertisement is educational simply because it contains medical information. The intended purpose, context, presentation, and compliance conditions need to be examined.

Before using any patient-related material, ask the medical and legal reviewers to confirm the proposed purpose, consent requirements, identification risks, and whether the use is permitted. If the material is not necessary, leave it out. Patient dignity should take priority over visual impact.

4.2 What are the risks of fake reviews and manipulated engagement?

Fake followers and purchased likes can make a profile look popular without demonstrating genuine public trust. In healthcare, the problem goes beyond vanity metrics. A patient may interpret a large follower count, strong rating, or stream of glowing reviews as evidence of clinical quality.

The guidelines prohibit manipulation of digital engagement, including fake followers, likes, reviews, ratings, testimonials, comments, views, and other forms of digital activity. They also address attempts to manipulate search rankings or algorithms to create a misleading impression of professional standing.

Consequently, agencies should not buy engagement or promise artificial ranking improvements to doctors and hospitals. They should also avoid arranging fabricated patient reviews or using deceptive tactics to suppress criticism. Legitimate reputation management should focus on accurate information, respectful responses, service improvements, and appropriate complaint-handling processes.

A hospital can still track meaningful indicators of its digital communication. For example, it can measure visits to educational pages, completion of public-health videos, or engagement with general awareness material. However, those numbers should not be presented as proof of better treatment outcomes or superior medical skill. Metrics need context, and clinical claims require suitable evidence.

4.3 What do the NMC guidelines say about AI-generated content?

AI can help communication teams with drafting, editing, translation, captions, accessibility, and other tasks. However, the new guidelines place explicit restrictions on AI in medical advertising. They prohibit AI-generated promotional campaigns for commercial interest and restrict AI-generated or AI-assisted content that misleads people about diagnosis, treatment, clinical outcomes, qualifications, patient experiences, or healthcare services.

The guidelines also prohibit using AI to create or manipulate patient images, testimonials, voices, clinical outcomes, or synthetic endorsements that appear to come from a real patient, doctor, or other person. They address disclosure where AI-generated or materially altered content could affect how an audience understands the communication. AI use involving patient information must also comply with applicable privacy and confidentiality requirements.

For marketing teams, this means that an AI tool should not be used to invent a patient success story, fabricate a doctor speaking on camera, or create a synthetic patient praising a hospital. Nor should an agency assume that adding an “AI-generated” label makes prohibited commercial promotion acceptable.

Before using AI, document the task, the source material, the human review, and the intended use. Never enter identifiable patient information into an AI tool unless the use is authorised and meets the applicable requirements. In uncertain cases, obtain legal and compliance guidance before publishing.

4.4 Can a hospital offer discounts, coupons, or limited-period promotions?

The guidelines address promotional offers that could encourage unnecessary healthcare consumption. Doctors and hospitals should not assume that standard retail tactics—such as flash sales, contests, cashbacks, gifts, or limited-time offers—are suitable for medical services.

Healthcare decisions are different from routine consumer purchases. A person may feel pressured by a countdown, a discount, or a message suggesting that they will lose a treatment opportunity. The concern becomes greater when the offer encourages unnecessary consultations, diagnostic tests, or procedures.

Instead of using urgency-based marketing, healthcare providers should prioritise factual information. A communication can explain the service, the relevant department, accessibility arrangements, or how patients can obtain further information, where permitted. It should not create fear or pressure people into unnecessary care.

Before approving an offer, assess its purpose, eligibility conditions, potential effect on patient decisions, and the rules that apply to the service. Do not assume that a discount becomes acceptable because it is delivered through an influencer or a third-party website. The substance of the offer matters more than the channel.

5. A Practical Compliance Checklist for Healthcare Marketing Teams

The best time to find a compliance problem is before filming, not after a video starts circulating. Hospitals, agencies, and creators should build review into the campaign process from the first brief. This reduces wasted production costs and gives every participant a clearer understanding of the limits.

Start by identifying the activity. Is it public-health education, an academic discussion, factual communication about facilities, or promotion of a doctor’s services? Next, review the claims, people featured, product references, audience, and call to action. If the concept relies on a prohibited endorsement or patient testimonial, changing the caption may not solve the problem.

A clear approval process should include a clinical reviewer and, where needed, a legal or compliance reviewer. The team should preserve the final script, source references, approvals, permissions, and published version. It should also decide who can correct or remove the content if a problem emerges.

5.1 Before publishing a healthcare video, check these points

• Purpose: Does the content provide permitted information, or does it solicit patients or promote a doctor’s personal practice?
• Claims: Can each factual medical statement be verified using reliable evidence?
• Promises: Does the content avoid guaranteed cures, unsupported success rates, and exaggerated claims?
• Endorsements: Does it avoid prohibited endorsements of medical services or commercial health products?
• Creators: Has the team checked whether the proposed third-party collaboration itself is permitted?
• Patient privacy: Does the content avoid unauthorised or prohibited use of patient images, stories, records, and identifiable details?
• Testimonials: Has the team avoided treating consent as automatic permission for otherwise prohibited promotional content?
• AI: Has the team checked the rules before using AI-generated or AI-assisted material?
• Engagement: Does the campaign avoid fake reviews, purchased engagement, and misleading popularity signals?
• Offers: Does it avoid incentives that may encourage unnecessary healthcare consumption?
• Approval: Has the appropriate clinical, legal, and institutional reviewer approved the final version?
• Records: Can the team retrieve the brief, script, sources, permissions, and approval history if questioned later?

This checklist is a starting point, not a guarantee of compliance. Teams must check the full guidelines and other laws that apply to the proposed content. A campaign that passes a general marketing checklist may still breach a specific professional or statutory requirement.

5.2 What should agencies change in their campaign workflow?

First, add a compliance screening stage before pitching a concept. The agency should identify whether the campaign involves a registered medical practitioner, a healthcare institution, a medicine, a device, a patient story, or a commercial health claim. If the concept depends on a prohibited activity, stop and redesign it before spending money on production.

Second, separate clinical review from creative approval. A script can be entertaining and still contain an inaccurate medical claim. A clinician should review medical accuracy, while a compliance reviewer should assess the campaign’s purpose and promotional features. Neither approval should replace the other.

Third, build a documented approval trail. Save the original brief, revised scripts, verified claims, final edits, and publication approval. Make sure the person approving the content has the authority and knowledge to do so. For multi-location hospital groups, also check whether state-level requirements differ.

Finally, create a post-publication response plan. If a claim proves inaccurate or a privacy concern emerges, the team needs a clear process to review, correct, or remove content where appropriate. Assign responsibility before launch rather than deciding during a crisis.

5.3 What can brands measure when direct promotion is restricted?

Marketing teams may need to change how they define success. If a campaign cannot use direct patient solicitation, celebrity endorsements, or promotional testimonials, that does not mean all useful communication must stop. Permitted educational activity can still be evaluated against suitable communication goals.

For example, a public-health video might aim to improve understanding of a preventive measure. Relevant measures could include completion rates, engagement with educational resources, or audience responses that show whether the message was understood. Those metrics do not prove improved health outcomes, but they can help evaluate communication quality.

Teams should also distinguish attention from clinical impact. Views, shares, and follower growth do not prove that a treatment works or that a hospital delivers better care. Likewise, an increase in appointment enquiries does not automatically establish that an educational campaign complied with the rules.

Use measurement plans that match the permitted purpose. Define the audience, message, learning objective, and evaluation method before publication. Avoid turning educational content into a disguised patient-acquisition funnel. When a campaign’s legal status is unclear, resolve that issue before deciding which performance indicators to optimise.

6. What Healthcare Brands Should Do Next

The NMC guidelines 2026 for doctors and hospitals require healthcare marketers to rethink the role of influencers, social media, AI, and patient stories. The central question is not whether a format is popular. It is whether the activity is permitted, truthful, patient-centred, and consistent with the professional and legal framework.

Healthcare communication can still serve an important public purpose. Doctors and institutions can share permitted health information, support public-health awareness, and take part in educational discussions within the applicable conditions. However, agencies should not treat these activities as a loophole for promotional campaigns.

Key takeaways for doctors, hospitals, creators, and agencies

• Read the current rules: Use the NMC’s official October 2026 guidelines rather than relying on outdated summaries.
• Separate education from promotion: A video about a health topic is not automatically compliant if it solicits patients.
• Screen influencer briefs early: Third-party involvement does not remove the responsibility of a doctor or institution for content they authorise or knowingly permit.
• Avoid prohibited endorsements: Do not use doctors’ professional status to promote products or services in ways the guidelines prohibit.
• Protect patients: Consent alone does not make every testimonial, before-and-after image, or success story permissible.
• Review AI carefully: Do not use AI to fabricate patients, clinical outcomes, or endorsements, and observe the restrictions on AI-generated promotional campaigns.
• Reject artificial engagement: Do not purchase fake followers, reviews, likes, views, or ratings.
• Keep records: Save evidence, approvals, and the final published content.
• Seek legal advice: Ask a qualified professional to review uncertain cases before production or publication.
• Put patient interests first: Trustworthy communication should inform people rather than pressure them into treatment.

About Hobo.Video

Hobo.Video is India’s leading AI-powered influencer marketing and UGC company. With over 2.25 million creators, it delivers end-to-end campaign management designed for brand growth. The platform blends AI intelligence with human strategy to ensure maximum ROI.

Services include:

• Influencer marketing
• UGC content creation
• Celebrity endorsements
• Product feedback and testing
• Marketplace and seller reputation management
• Regional and niche influencer campaigns

Trusted by top brands like Himalaya, Wipro, Symphony, Baidyanath, and Good Glamm Group.

Inspired by what you read? Let’s turn ideas into impact. Connect with us and unlock your brand’s next growth chapter. Start here.
If you’re an influencer looking for real brand growth, this is your moment. Join now.